Results 131 to 140 of about 2,402,251 (269)

Audiovestibular findings in beta-thalassemia patients receiving chelation therapy: an observational cross-sectional study

The Egyptian Journal of Otolaryngology
Background Iron chelators, including deferasirox, deferiprone, and deferoxamine, are used to reduce iron overload in patients with beta thalassemia. Deferoxamine has the most consistently reported dose- and duration-related ototoxic profile, whereas ...
Hasan Demir, Süleyman Özdemir, Göksel Leblebisatan, Hatice İlgen Şaşmaz, Özgür Sürmelioğlu, Ahmet Atila, Mustafa Mete Kıroğlu, Muhammed Dağkıran, Elvan Onan, Çağlar Eker   +9 more
doaj   +1 more source

The trial to assess chelation therapy 2 (TACT2): Rationale and design. [PDF]

Am Heart J, 2022
Lamas GA, Anstrom KJ, Navas-Acien A, Boineau R, Kim H, Rosenberg Y, Stylianou M, Jones TLZ, Joubert BR, Santella RM, Escolar E, Aude YW, Fonseca V, Elliott T, Lewis EF, Farkouh ME, Nathan DM, Mon AC, Gosnell L, Newman JD, Mark DB, TACT2 Investigators.   +21 more
europepmc   +1 more source

Chelation Therapy in the Treatment of Metal Intoxication

, 2016
Chelation Therapy in the Treatment of Metal Intoxication presents a practical guide to the use of chelation therapy, from its basic chemistry, to available chelating antidotes, and the application of chelating agents.

core  

Evaluation of Cardiac Systolic and Diastolic Function by Echocardiographic Tei Index in Thalassemic Patients Referring to HazrateMasoumeh Hospital, Qom, Iran, 2012-2013

Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Qum, 2015
Background and Objectives: Early diagnosis of secondary cardiac involvement due to iron overload is very important in thalassemia patients. The aim of this study was to evaluate cardiac systolic and diastolic function by Tei Index in patients with β-
Mohammad Hossein Arjmandnia, Parvaneh Sadeghi Moghaddam, Seyed Kamal Eshagh Hosseini, Hamed Hassani, Mohammad Aghaali   +4 more
doaj  

Adherence to Iron Chelation Therapy among Adults with Thalassemia: A Systematic Review. [PDF]

Hemoglobin, 2022
Locke M, Reddy PS, Badawy SM.
europepmc   +1 more source

Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or thalassaemia. [PDF]

Cochrane Database Syst Rev, 2023
Geneen LJ, Dorée C, Estcourt LJ.
europepmc   +1 more source

An AN OBSERVATIONAL STUDY OF LIVER FUNCTIONS IN MULTIPLE TRANSFUSED THALASSEMIA PATIENTS ON REGULAR CHELATION THERAPY VERSUS IRREGULAR CHELATION THERAPY IN A TERTIARY CARE CENTER OF JAIPUR, RAJASTHAN

Objectives: The aim of our study was to determine liver functions in thalassemia patients on regular versus irregular chelation therapy. Methods: This was an observational study conducted in the department of pediatrics in a tertiary care hospital ...
YADAV, SHWETA, SHARMA, ABHISHEK KUMAR, YADAV, RAJVEER SINGH, GOYAL, TRAPTA, PAL, NIKITA, RAY, SANDIP   +5 more
core   +1 more source

Chelation Therapy Associated with Antioxidant Supplementation Can Decrease Oxidative Stress and Inflammation in Multiple Sclerosis: Preliminary Results. [PDF]

Antioxidants (Basel), 2023
Vezzoli A, Mrakic-Sposta S, Dellanoce C, Montorsi M, Vietti D, Ferrero ME.   +5 more
europepmc   +1 more source

Chelation Therapy in Patients With Cardiovascular Disease: A Systematic Review. [PDF]

J Am Heart Assoc, 2022
Ravalli F, Vela Parada X, Ujueta F, Pinotti R, Anstrom KJ, Lamas GA, Navas-Acien A.   +6 more
europepmc   +1 more source

Impact of iron chelation therapy on thyroid function in beta-thalassemia major patients from Pakistan. [PDF]

Sci Rep
Shah AWA, Shams S, Khan MJ, Ullah N, Ullah MJ, Inayat F.   +5 more
europepmc   +1 more source